Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
China channel feed
Ahead of FDA decision on BTK drug, Amgen-partnered BeiGene is one step closer to China OK for PD-1
6 years ago
FDA+
ARCH-backed Chinese biotech scores PhIII win for glucokinase-modulating diabetes drug
6 years ago
R&D
Tot Biopharm completes HKEX listing, raising $63M in modest debut
6 years ago
Financing
Alzheimer's breakthrough? Not so fast — experts poke holes in data underlying China's surprise approval
6 years ago
In Focus
AstraZeneca sketches plans for a $1B venture fund — and it's going to China
6 years ago
Financing
Sino Biopharm, OrbiMed back Merck-partnered Akesobio's bet on made-in-China antibodies
6 years ago
Financing
Alzheimer's stunner: Chinese biotech wins OK for a new drug on positive data — and they have some high-profile supporters
6 years ago
FDA+
Amgen takes a $2.7B stake in BeiGene, gaining a prominent ally in China to help seize a leading role in cancer drug commercialization and development
6 years ago
Deals
In a bid to get to Chinese patients faster, Shanghai's I-Mab plans $100M Nasdaq IPO
6 years ago
Financing
Ascentage soars during its first day on the Hong Kong exchange, following $53M debut
6 years ago
Financing
China's Fountain Medical scores $62M as demand for CRO services surges
6 years ago
Financing
Outsourcing
Merck KGaA wants to get in early on Chinese innovation — so it's setting up a seed fund there
6 years ago
Financing
Following top-level C-suite departures, Ascletis raids Novartis for R&D exec
6 years ago
People
San Diego couple charged with stealing trade secrets, opening Chinese biotech as DOJ crackdown continues
6 years ago
R&D
Cancer drugs among US goods spared from tariffs as China issues first exemptions in trade war
6 years ago
How about a $477M biotech IPO amid Hong Kong protests? Henlius will find out
6 years ago
Financing
Hong Kong strife holds up almost $100M of BioNTech's Series B haul
6 years ago
Financing
Private equity meets China biotech: PAG infuses $540M to gain control of Hisun's biosimilar subsidiary
6 years ago
Deals
Building on successful PD-1 pact, Eli Lilly licenses diabetes drug to Chinese partners at Innovent
6 years ago
Deals
Biotech leaders rally behind Chinese scientists in US, calls for 'measured' policies in wake of purges
6 years ago
China has become a CEO-level priority for multinational pharmaceutical companies: the trend and the implications
6 years ago
Biotech Voices
Preferential tax policies coming for biopharmas setting up shop in Shanghai's newest free trade zone
6 years ago
Move over, Hong Kong: Shanghai’s new tech board sees fervent demand for maiden biotech IPO
6 years ago
Financing
Following footsteps of chart-topping Chinese counterparts, Alphamab Oncology files IPO at HKEX
6 years ago
Financing
First page
Previous page
19
20
21
22
23
24
25
Next page
Last page